Activation of viral defense signaling in cancer
Maria Gonzalez-Cao, Niki Karachaliou, Mariacarmela Santarpia and 3 more
Therapeutic Advances in Medical Oncology · 2018
doi:10.1177/1758835918793105 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
A coordinated action of innate and adaptive immune responses is required to efficiently combat a microbial infection. It has now become clear that cancer therapies also largely benefit when both arms of the immune response are engaged. In this review, we will briefly describe the current knowledge of innate immunity and how this can be utilized to prime tumors for a better response to immune checkpoint inhibitors. Comments on compounds in development and ongoing clinical trials will be provided.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.